Evidence map›Paper›PMID 25349395›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Developing functional musculoskeletal tissues through hypoxia and lysyl oxidase-induced collagen cross-linking.

Eleftherios A Makris, Donald J Responte, Nikolaos K Paschos, Jerry C Hu, Kyriacos A Athanasiou

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 151 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. LOXL2 alleviates post-traumatic knee osteoarthritis and pain.Journal of orthopaedic translation · 2025
    Article
  6. Review
  7. Age-related changes in the quadriceps tendon: Collagen fibril diameter decreases with aging.Asia-Pacific journal of sports medicine, arthroscopy, rehabilitation and technology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Eleftherios A MakrisDepartments of Biomedical Engineering and.
Donald J ResponteDepartments of Biomedical Engineering and.
Nikolaos K PaschosDepartments of Biomedical Engineering and.ORCID http://orcid.org/0000-0002-1689-6636
Jerry C HuDepartments of Biomedical Engineering and.
Kyriacos A AthanasiouDepartments of Biomedical Engineering and Orthopedic Surgery, University of California, Davis, CA 95616 athanasiou@ucdavis.edu.
University of California, Davis · US

Funding

Regenerating the fibrocartilage spectrum of the TMJ: from disc to condyleR01DE019666 · NIDCR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ATHANASIOU, KYRIACOS A · 2010 to 2013
$1.4M
Self-Assembling Process in Tissue Engineering of Articular CartilageR01AR053286 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ATHANASIOU, KYRIACOS A · 2007 to 2011
$1.3M
NIAMS NIH HHS R01 AR053286NIAMS NIH HHS R01AR053286NIDCR NIH HHS R01 DE019666NIDCR NIH HHS R01DE019666
6 · The paper itself

Abstract

The inability to recapitulate native tissue biomechanics, especially tensile properties, hinders progress in regenerative medicine. To address this problem, strategies have focused on enhancing collagen production. However, manipulating collagen cross-links, ubiquitous throughout all tissues and conferring mechanical integrity, has been underinvestigated. A series of studies examined the effects of lysyl oxidase (LOX), the enzyme responsible for the formation of collagen cross-links. Hypoxia-induced endogenous LOX was applied in multiple musculoskeletal tissues (i.e., cartilage, meniscus, tendons, ligaments). Results of these studies showed that both native and engineered tissues are enhanced by invoking a mechanism of hypoxia-induced pyridinoline (PYR) cross-links via intermediaries like LOX. Hypoxia was shown to enhance PYR cross-linking 1.4- to 6.4-fold and, concomitantly, to increase the tensile properties of collagen-rich tissues 1.3- to 2.2-fold. Direct administration of exogenous LOX was applied in native cartilage and neocartilage generated using a scaffold-free, self-assembling process of primary chondrocytes. Exogenous LOX was found to enhance native tissue tensile properties 1.9-fold. LOX concentration- and time-dependent increases in PYR content (∼ 16-fold compared with controls) and tensile properties (approximately fivefold compared with controls) of neocartilage were also detected, resulting in properties on par with native tissue. Finally, in vivo subcutaneous implantation of LOX-treated neocartilage in nude mice promoted further maturation of the neotissue, enhancing tensile and PYR content approximately threefold and 14-fold, respectively, compared with in vitro controls. Collectively, these results provide the first report, to our knowledge, of endogenous (hypoxia-induced) and exogenous LOX applications for promoting collagen cross-linking and improving the tensile properties of a spectrum of native and engineered tissues both in vitro and in vivo.

Indexed as

AnimalsCattleCell HypoxiaCells, CulturedChondrocytesCollagenLigamentsMaleMenisci, TibialMiceMice, NudeProtein-Lysine 6-OxidaseTendonsTissue EngineeringCollagenProtein-Lysine 6-Oxidasecollagen cross-linkinglysyl oxidasemusculoskeletal tissuespyridinolinetissue engineering

Identifiers

PMID25349395
PMCPMC4234579
OpenAlexW2109415576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.